Chinese Stocks Lead Sudden Dip in Risk Assets Before Trade Talks
A gauge of Chinese stocks in Hong Kong fell as much as 0.9%, after earlier rising 0.5%. The CSI 300 Index, a benchmark for onshore shares, also flipped to a loss. US equity futures retreated from the day's high.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Tesla, Inc. (TSLA) Isn't Being Targeted By Trump's Copper Tariffs, Says Jim Cramer
We recently published . ABC is one of the stocks Jim Cramer recently discussed. Tesla, Inc. (NASDAQ:TSLA) is the world's largest electric vehicle manufacturer. Cramer has discussed the firm regularly in his morning shows this year. The CNBC TV host believes that Tesla, Inc. (NASDAQ:TSLA) narrative should be driven by humanoid robots and self-driving instead of EV deliveries. The shares have lost 18.3% year-to-date as investors have fluctuated from being optimistic about self-driving and robotaxi plans to worrying about Musk's tensions with President Trump and falling vehicle deliveries. Cramer discussed Tesla, Inc. (NASDAQ:TSLA) in the context of President Trump announcing a 50% tariff on copper: 'Okay so Tesla has a 180 pounds of copper. These electric vehicles are filled with copper. And a typical ICE vehicle has far fewer. Now candidly, Musk is trying to get this down to 40 pounds. But if you didn't know better you would say boy this is really aimed at, at Tesla. . . If I were Elon, which I'm most certainly not. . .I would say holy, he's coming after me, I'm a copper user. But everybody uses copper. . . most of the world's copper is used by China.' Previously, Cramer had discussed Tesla, Inc. (NASDAQ:TSLA) after a William Blair downgrade: '[On William Blair downgrade citing EV and regulatory credit loss as driving the decison] I read and plus the story about China and how they're lagging. And I come back and say okay, when you make those two points, tomorrow there'll be someone who says, look it's not a caa company. It's humanoid and it's self driving. And that ability to be able to select why you like the stock of Tesla is something that is beginning to annoy me. I happen to like Tesla but I'm just saying I like it for humanoid, I like it for self driving. Forget about the car because those are better markets. But these guys are like, the deliveries are bad, I'm gonna downgrade. You know come on, just be consistent. Be consistent. This thing is a juggernaut when it comes to humanoid and when it comes to self driving and that's what I care about.' While we acknowledge the potential of TSLA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
an hour ago
- Yahoo
Here are investors' burning AI questions with tech earnings around the corner
AI has powered the market to all-time highs. But this earnings season will be an important moment for Big Tech to show that massive AI spending is paying off. Here are three big questions investors have about AI before tech earnings kick off this month. Big Tech companies are soon going to let investors know if all the hype is still worth it. Amid tariff turmoil and market uncertainty, the tech trade continues to power the S&P 500 higher. With mega-cap tech earnings due to kick off later this month, investors are looking for clues to know if the AI-fueled momentum can keep powering stocks higher. The launch of DeepSeek—a cost-efficient AI model from a startup in China—was an "existential moment" for the AI trade, according to Eric Sheridan, co-business unit leader of the TMT group at Goldman Sachs. "There's an increasing focus on the payoff or the return dynamic," Sheridan told Business Insider. "How are we seeing enterprises use AI? How are we seeing consumers adopt AI applications in their day-to-day life? Is AI technology delivering on its promise of increasing productivity and profit margins? Investors will soon be turning to second-quarter earnings season for answers. Big Tech companies have poured billions into building out AI infrastructure, and there's a lot of debate on Wall Street about how much more companies can spend. As of February, Amazon, Microsoft, Alphabet, and Meta's total AI investment for 2025 was over $300 billion, a notable increase from the $246 billion spent in 2024. Competition in the AI space is fierce as Big Tech companies race to develop better large language models. And it's still early stages, meaning that this level of capital expenditure could persist well into the future. "There's still pretty low visibility into what they're going to spend next year," Sheridan said of the Big Tech companies. "I wouldn't put a high probability on a slowdown," he added. A lot of money and effort is being poured into AI tools for companies, but investors want a clearer sign of what it all means. Investors will look for clues on earnings calls that AI adoption is accelerating. They're not just interested in whether Nvidia beats consensus expectations; they're also looking for more widespread adoption of AI among other companies. Investors have reasons to be optimistic, as there have been green shoots in previous months. The earliest signs of AI adoption have been showing up primarily in the software industry as companies adopt agentic AI to complete tasks autonomously. According to Bank of America, earnings calls of Russell 2000 companies have mentioned AI more frequently over the last few quarters. This quarter's earnings season will be key to determining whether the trend holds. In June, Bank of America identified software winners, including Microsoft, Salesforce, and ServiceNow. The bank expects monetization to begin taking off in 2026. For Big Tech, the pressure is on to show strong software margins. "We think the AI backdrop is a big stimulant for the cloud computing businesses on the revenue side," Sheridan said. "And we'll be looking for some proof points around that through earnings season as well." First-quarter earnings were stronger than expected despite uncertainty related to tariffs. That's mostly thanks to Big Tech, and investors are watching to see if the sector can continue to lead to outperformance again. Nadia Lovell, senior US equity strategist at UBS Global Wealth Management, believes AI will continue to be the primary driver of earnings growth across the S&P 500. "Yes, there might be vulnerability, but we need to focus on those secular and structural growth stories, like AI power and resources," Lovell said at the bank's roundtable on July 8. Tariffs are putting extra pressure on the AI trade, as investors are worried about higher import costs eating into company margins. Could AI use cases provide a shield against tariff headwinds? Jeremy Siegel, Wharton professor and senior economist at WisdomTree, thinks firms need to start showing investors that they're putting AI to use, especially as tariffs drag on consumer sentiment. "I think they're going to have to do it very soon, facing some of these tariff price increases," Siegel said on CNBC on Friday. Read the original article on Business Insider Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Cardinal Health (NYSE:CAH) Launches One Voice Initiative Supporting Independent Pharmacy Advocacy
Cardinal Health recently launched its Cardinal Health™ One Voice Initiative, a move aimed at advocating for independent pharmacies, which aligns with the company's broader strategic efforts in product development and community support. Over the last quarter, the company's stock price rose by 22%, reflecting not only this initiative but also the increased dividend payout, which may have appealed to income-focused investors. Furthermore, Cardinal Health's inclusion in the Russell 1000 indices and a significant uptick in earnings contributed positively to investor sentiment. These developments collectively underscore the company's ability to enhance shareholder value in a relatively stable market. We've identified 1 risk for Cardinal Health that you should be aware of. These 14 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. The One Voice Initiative reflects well on Cardinal Health's commitment to its independent pharmacy customers and could help bolster its brand reputation and customer satisfaction. This initiative, alongside a stronger dividend payout, aligns with its strategic emphasis on enhancing community support and product development. Over the past five years, Cardinal Health's total shareholder return, including dividends, was approximately 246.58%. This performance over the period positively positions it against the one-year broader US Healthcare industry return of 22.1% decline, demonstrating significant resilience and competitive strength. The company's strategic acquisitions and expanded manufacturing capabilities are pivotal in enhancing revenue streams. Analysts forecast annual revenue growth of 8.1%, underlined by strong performance in segments like Specialty Solutions and the onboarding of key clients like Publix. Earnings are projected to grow from US$1.6 billion to US$2 billion by May 2028. However, tariff risks and macroeconomic challenges could challenge these forecasts by impacting margins and cost structures. With a current share price of US$151.69, a discount to the consensus price target of US$175.81 suggests the market might anticipate future growth to align with analyst projections. The forecast earnings growth and other operational improvements support a fair valuation, though investors should balance these expectations with potential tariff impacts and broader economic volatility. This careful balance will likely influence Cardinal Health's trajectory in aligning with or exceeding the industry benchmarks in the coming years. Gain insights into Cardinal Health's future direction by reviewing our growth report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:CAH. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
